Janux Therapeutics, Inc. (JANX)
NASDAQ: JANX · Real-Time Price · USD
13.98
+0.14 (1.01%)
At close: Mar 9, 2026, 4:00 PM EDT
13.78
-0.20 (-1.43%)
After-hours: Mar 9, 2026, 5:05 PM EDT
Janux Therapeutics Market Cap
Janux Therapeutics has a market cap or net worth of $850.43 million as of March 9, 2026. Its market cap has decreased by -60.32% in one year.
Market Cap
850.43M
Enterprise Value
-107.38M
1-Year Change
-60.32%
Ranking
Category
Stock Price
$13.98
Market Cap Chart
Since the IPO on June 11, 2021, Janux Therapeutics's market cap has increased from $613.73M to $850.43M, an increase of 38.57%. That is a compound annual growth rate of 7.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 841.91M | 1.43% |
| Dec 31, 2025 | 830.04M | -73.11% |
| Dec 31, 2024 | 3.09B | 523.34% |
| Dec 29, 2023 | 495.20M | -9.51% |
| Dec 30, 2022 | 547.22M | -33.35% |
| Dec 31, 2021 | 821.00M | 33.77% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Arbutus Biopharma | 871.23M |
| Arvinas | 869.87M |
| Phathom Pharmaceuticals | 840.78M |
| Sana Biotechnology | 840.63M |
| Evommune | 835.39M |
| BridgeBio Oncology Therapeutics | 833.48M |
| Xencor | 830.19M |
| KalVista Pharmaceuticals | 820.37M |